EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION
Clinical trials for EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION trials appear
Sign up with your email to follow new studies for EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive new cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first-ever study in people for a new drug called EPI-326. It aims to find a safe dose and see how the body handles the drug in patients with advanced lung cancer (with a specific genetic change called EGFR mutation) or advanced head and neck cancer. The main goal is t…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Real-World lung cancer treatment study seeks to uncover which standard regimen works best
Disease control Recruiting nowThis study aims to collect information from routine medical practice to better understand the safety and effectiveness of two standard treatment options for advanced lung cancer with a specific genetic change (EGFR mutation). It will observe about 538 patients who are already rec…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION
Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC